Clinical Trial Update: Ambrisentan in Single Ventricle [Phase 2]

View source ↗

Summary

A Phase 2 trial of ambrisentan in single-ventricle physiology (hypoplastic left/right heart complex) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome
• Hypoplastic Right-sided Heart Complex

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

Sponsor: Kevin Hill | Conditions: Hypoplastic Left Heart Syndrome, Hypoplastic Right-sided Heart Complex | Phase 2 | Status: COMPLETED | Results posted: 2019-09-12